Save the date for our next SPOOKY 👀 Journal club: ZENITH Journal Club Fri, Oct. 31, 12 p.m. ET More Info: site.thoracic.org/events/zenit... @sandeepsahaymd.bsky.social @atscommunity.bsky.social @ats-assemblies.bsky.social @atsearlycareer.bsky.social @pvrinstitute.bsky.social @phassociation.org

PH-inishing the AM off strong (standing room only 👀) at #PHPN2025 w/ Dr. Anjali Vaidya: “PHocus on the Right Heart: Clinical application of the new 2025 Right Heart Echocardiography Guidelines” Don’t PH-orget: septal flattening in systole, 🫀effusion, TAPSE,RVOT inflow, &more! @phassociation.org

💡session this morning looking to the PH-uture at #PHPN2025: “Adjunctive Stem and Progenitor Cell Therapy Approaches to Management of Pulmonary Arterial Hypertension” with Dr. Michael Lewis. @phassociation.org

The 2026 ATS New Faculty Boot Camp will have tailored sessions for the Basic (PhD) Scientist track. Also, for the first time, non-U.S./Canadian residents can apply for admittance to the 2026 Basic (PhD) Scientist track! Registration details coming soon for 2026!

How PH-antastic to have not 1 but 2 🌟 pulmonary vascular meetings this week: #PHPN2025 and the PERT consortium, #PERT2025! Hope all @ats-pc.bsky.social members and #PHPeeps attending have a safe trip and wonderful time! And don’t forget to tag us 😎 #PH #PVD #RV #PE @phassociation.org

Troy Stevens, PhD presenting the Terry Wagner Memorial Lecture: Impact of Age on Endothelial Heterogeneity in the Pulmonary Vasculature @ats-pc.bsky.social #groverconference2025

🎉 Congratulations to Dr. Troy Stevens on receiving the Terry Wagner Memorial Lecture Award! A well-deserved honor recognizing his outstanding contributions. @ats-pc.bsky.social

🎉 Congratulations to Dr. Courtney Stockman on her Grover impactful abstract presentation: "The Two Faces of β-Catenin in the Distal Lung Endothelium: Homeostasis, Injury, and Regeneration." @ats-pc.bsky.social

👏Congratulations to Dr. Susan Majka, for the Estelle B. Grover Memorial Lecture: Aging Impacts the Heterogeneity of Adult Pulmonary Vascular Progenitors & Angiogenesis in CLD @ats-pc.bsky.social

Congratulations to Dr. @alexandraracanelli.bsky.social on her impactful abstract presentation: “The Role of Endothelial TBX3 in the Pathogenesis of Pulmonary Arterial Hypertension.” An exciting contribution to advancing our understanding of PAH — well done! 👏 @ats-pc.bsky.social

Congratulations to Dr. Joel James on his compelling abstract presentation: “Targeting 14-3-3 Protein–Mediated Endothelial-Pericyte Crosstalk as a Therapeutic Strategy in Pulmonary Hypertension.” Innovative science driving new possibilities in PH research! 👏🫁 @ats-pc.bsky.social

🔥🔥Grover Conference Fireside Chats #groverconference2025 @ats-pc.bsky.social

👏 Congratulations to Dr. Norbert Voelkel on delivering the prestigious John T. Reeves Memorial Lecture, highlighting oxidative stress, mitochondrial dysfunction, and the complex challenge of vascular aging. A powerful contribution to pulmonary and vascular science! @ats-pc.bsky.social

🎉 Huge congratulations to Dr. Rebecca Vanderpool @rrvdpool.bsky.social on her compelling abstract presentation: Association of RV Endocardial Radiomics with Age in Patients with Pulmonary Hypertension. 👏🫀 @ats-pc.bsky.social

🎉 Congratulations to Dr. Karina Massad on presenting her impactful abstract: "Determining Distinct Pulmonary Artery Endothelial Cell Phenotypes in PAH and COPD-PH" 👏🫁 @ats-pc.bsky.social

👏 We're thrilled to congratulate Dr. Claudia Mickael on her compelling abstract presentation: “CD301b⁺ cDC2s, but not Batf3⁺ cDC1s, Mediate Hypoxia-Induced Pulmonary Hypertension via Subset-Specific Activation Programs”. @ats-pc.bsky.social

🎊Big congratulations to Dr. Sharon I.S. Rounds, MD, ATSF, for delivering the Robyn J. Barst Memorial Lecture: 🫁 “The Aging Pulmonary Vasculature: Intersection of Inflammation and Injury in CLD.” Such a timely and important topic in chronic lung disease research. 👏 @ats-pc.bsky.social

🌟 Congratulations to Dr. Caitlin Lewis on presenting her groundbreaking abstract: Lyve1⁺ Interstitial Macrophages Undergo Hypoxia-Induced Reprogramming to Promote Vascular Remodeling and Pulmonary Hypertension. 👏 @ats-pc.bsky.social

🎉Congratulations to Kel Vin Woo, MD, PhD on his abstract presentation: “ Fibroblast Growth Factor Signaling Vascular Smooth Muscle Plasticity and Protects Against Hypoxia Induced Pulmonary Hypertension”. Exciting work! 👏 @ats-pc.bsky.social

🌟🌟 Current and Past Colorado faculty and fellows at Grover Conference! An amazing legacy left by the giants who created the CVP and started the Grover Conference! #GroverConference2025 @suegumd.bsky.social @timlahm.bsky.social @ats-assemblies.bsky.social @atscommunity.bsky.social

Check out the September issue of our @ats-pc.bsky.social #ECPWG newsletter - including updates and ways to get involved! @suegumd.bsky.social @navneetsinghmd.bsky.social @atsearlycareer.bsky.social @ats-assemblies.bsky.social atspcecwg.my.canva.site/ats-pc-ecpwg...

📣📣 We are thrilled that it is finally time for the 2025 #GroverConference! What a PH-antastic opportunity for all #PVD #PH #RV enthusiasts to gather & learn together! For all those attending, tag @ats-pc.bsky.social so we can highlight all things Grover! @ats-assemblies.bsky.social

Want to know who's making waves in the pulmonary vascular disease world? (pun intended 🌊) Here's another early career highlight! 🥁 Meet Dr. Gu:

Ready for a walk by the canals?? 📢WSPH Association is proud and happy to announce that the next World Symposium on Pulmonary Hypertension will be held in Amsterdam on July 1-4, 2029. Stay tuned for more details!📢 #WSPH2029 #WSPH #WSPHAssociation #PAH

Dr. Michael Karass wrote his latest PERTspective on "Development and implementation of an emergency alteplase kit for high-risk pulmonary embolism in cardiac arrest." Read the full journal article here: pubmed.ncbi.nlm.nih.gov/39658065/

Learn more about the STING signaling pathway in PAH! JCI Insight - Opposing roles for myeloid and smooth muscle cell STING in pulmonary hypertension insight.jci.org/articles/vie... @pvrinstitute.bsky.social @accpchest.bsky.social

Apply to attend our upcoming Academy of pulmonary hypertension! 📆 20–21 November, 2025 📌 Amsterdam, Netherlands The course will identify the different processes involved in diagnosing and managing #pulmonary hypertension. Apply before 21 July: bit.ly/41C3pey

The Impact of Cardiac Output Methods on the Classification of Pulmonary Hypertension - Genecand - 2025 - Pulmonary Circulation - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/... @pvrinstitute.bsky.social @atsblueeditor.bsky.social @pulmpeeps.bsky.social

Treatment With Oral or Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension and Cardiovascular Comorbidities - CHEST journal.chestnet.org/article/S001...

PVRI registration and abstract submission are open 🤓 x.com/PVRI/status/...

Happy Monday! Let's start the week right with an early career highlight 🥁 Introducing Dr. Forbes:

Viewpoint: a critique of pulmonary vascular resistance to define severe pulmonary hypertension publications.ersnet.org/content/erj/...

🗻 Next in our High Altitude series: 📅 1 July | 1PM BST 🎙️ Rahul Kumar on inflammatory immune cells in hypoxic PH Free & open to all — register: pvrinstitute.org/learning-hub... #PH #Hypoxia #HighAltitude #PVRIWebinars

Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR) @atscommunity.bsky.social‬ #PAH www.atsjournals.org/doi/full/10....

Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study @atscommunity.bsky.social‬ #PAH 🔓Open Access www.atsjournals.org/doi/full/10....

Serial Pulmonary Hemodynamics in Patients with Idiopathic Pulmonary Fibrosis Listed for Lung Transplant Pulmonary hypertension in #IPF progresses unpredictably, sometimes in an accelerated fashion ‪@inovahealth.bsky.social‬ 🔓Open Access www.atsjournals.org/doi/full/10....

📢 Get ready to submit your abstract to PVRI 2026 Dublin — registrations & the abstract portal will open on 1 July! Stay tuned for full details on how to register and submit your abstract! pvrinstitute.org/pvri2026 #PVRI2026 #PulmonaryHypertension #GlobalScience #Congress

Hot off the press 🔥: Check out this guideline summary on interventional strategies for children with progressive pulmonary hypertension in the June issue of Annals ATS. www.atsjournals.org/doi/full/10....

A great ERJ podcast where Dr. Marius Hoeper discusses the safety and efficacy of sotatercept! Your next listen on your commute home🎧🚗🚶‍♀️🚶 open.spotify.com/episode/2tEg...

Missing all the networking at ATS 2025? Here is a PC Assembly early career highlight! Meet Dr. Shen:

🩺 Join us for the @ats-pc.bsky.social journal club next week! 📅 Tue, June 3, 2025, 12pm ET 🎤 Presenter: Dr. Edda Spiekerkoetter, MD Register Now! thoracic.zoom.us/meeting/regi...

And with that, the PC Web Committee (Chair: Dr. Khushboo Goel / Co-Chair: Dr. Kathryn del Valle / Member: Dr. Katherine Cox-Flaherty) aka the PH-aparazzi is signing off #ATS2025! 📸 📹🤳We had a blast sharing all the PC action with you all. 👋👋👋 @atscommunity.bsky.social @atsearlycareer.bsky.social

I spy with my little eye exciting COPD-PH research in this Clinical Problems session! 🕵️‍♀️ Dr. Ryen Ormesher presents the potential link between miR126 and pulmonary vascular remodeling in COPD-PH. #ATS2025

The PHun doesn’t stop there! Head over to the Poster Discussion on Late-Breaking Abstracts in 3009/3011 or Mini Symposium on Novel Models of Metabolism and Vascular Remodeling in 2009/2011. 👟👟

Clinical and Epidemiologic Insights into PH Trends, Treatments, and Outcomes was one of the best poster discussions of the week! 🏆 Thanks to the PHenomenal moderators Dr. Cirulis, Roto, and Mihalek for curating such an amazing dialogue! 👏

You’ve heard of door-to-balloon time, but have you heard of door-to-thrombectomy time? 🤔⏳ Dr. Kunal Patel shows that every hour counts when it comes to #RV function in intermediate-risk PE patients.

Dr. Meghan Cirulis wearing many hats - both moderating and presenting her research on sexual dimorphism in RV adaptation in CTEPH patients

Dr. Balasubramanian shows that incorporating QoL metrics with emPHasis-10 further discriminates survival outcomes in low-risk #PH patients. #PVDOMICS

Dr. Sarah Khan challenging the status quo definition of “pulmonary vascular phenotype” with a CT-phenotyping methodology in CTD ILD-PH. Amazing work that will help push our field forward! 🤩 #HopkinsPCCM

Medicine Resident Dr. Taylor Caton presents her work on the impact of PAH therapy in COPD-PH outcomes. She is one of many future PVD ⭐️ #TemplePCCM